Form 4: Twist Bioscience COO Sells Shares to Cover Tax Obligations

Patrick John Finn, President and COO of Twist Bioscience, sold 206 shares of common stock on April 2, 2025, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• On April 2, 2025, Patrick John Finn, the President and COO of Twist Bioscience Corp, sold 206 shares of common stock.
• The sale was executed at a price of $38.733 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
• Following the transaction, Finn directly owns 267,518 shares of Twist Bioscience Corp.
• The sale was mandated by Twist Bioscience's equity incentive plans, requiring tax withholding obligations to be funded by a 'sell to cover' transaction.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is neither overtly positive nor negative, but rather a standard procedure for covering tax obligations.

Industry Context

Sales of shares to cover tax obligations are a routine part of equity compensation plans and are not necessarily indicative of a negative outlook on the company.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

Keywords

Twist Bioscience, TWST, Patrick John Finn, Stock Sale, Form 4, Insider Trading, Restricted Stock Units, Tax Withholding, Sell to Cover